| LCTX |
Lineage Cell Therapeutics, Inc. |
01 Jul 2025 |
1 |
$0 |
4 |
Director |
02 Jul 2025, 21:00 |
| GPCR |
Structure Therapeutics Inc. |
23 Jun 2025 |
1 |
$0 |
4 |
Director |
25 Jun 2025, 17:45 |
| /report/000095017025015322-russell-angus-c-2025-02-04 |
Revance Therapeutics, Inc. |
04 Feb 2025 |
2 |
-$133,247 |
4 |
Director |
06 Feb 2025, 15:45 |
| GPCR |
Structure Therapeutics Inc. |
26 Aug 2024 |
1 |
$0 |
4 |
Director |
28 Aug 2024, 16:37 |
| GPCR |
Structure Therapeutics Inc. |
26 Aug 2024 |
0 |
$0 |
3 |
Director |
28 Aug 2024, 16:35 |
| LCTX |
Lineage Cell Therapeutics, Inc. |
01 Jul 2024 |
1 |
$0 |
4 |
Director |
03 Jul 2024, 17:00 |
| /report/000147929024000089-russell-angus-c-2024-05-01 |
Revance Therapeutics, Inc. |
01 May 2024 |
2 |
$0 |
4 |
Director |
03 May 2024, 08:47 |
| LCTX |
Lineage Cell Therapeutics, Inc. |
01 Jul 2023 |
1 |
$0 |
4 |
Director |
03 Jul 2023, 17:46 |
| /report/000147929023000060-russell-angus-c-2023-05-03 |
Revance Therapeutics, Inc. |
03 May 2023 |
2 |
$0 |
4 |
Director |
05 May 2023, 17:14 |
| TXMD |
TherapeuticsMD, Inc. |
29 Sep 2022 |
1 |
$0 |
4 |
Director |
03 Oct 2022, 18:43 |
| TXMD |
TherapeuticsMD, Inc. |
18 Aug 2022 |
2 |
$0 |
4 |
Director |
22 Aug 2022, 06:00 |
| LCTX |
Lineage Cell Therapeutics, Inc. |
01 Jul 2022 |
1 |
$0 |
4 |
Director |
06 Jul 2022, 16:16 |
| /report/000089924322023428-russell-angus-c-2022-06-16 |
Mallinckrodt plc |
16 Jun 2022 |
0 |
$0 |
4 |
Director |
21 Jun 2022, 18:12 |
| /report/000147929022000071-russell-angus-c-2022-05-04-restatement |
Revance Therapeutics, Inc. |
04 May 2022 |
1 |
$0 |
4/A |
Director |
13 May 2022, 18:17 |
| /report/000147929021000173-russell-angus-c-2021-12-13 |
Revance Therapeutics, Inc. |
13 Dec 2021 |
1 |
+$100,741 |
4 |
Director |
15 Dec 2021, 19:17 |
| TXMD |
TherapeuticsMD, Inc. |
10 Aug 2021 |
2 |
$0 |
4 |
Director |
12 Aug 2021, 21:38 |
| TXMD |
TherapeuticsMD, Inc. |
01 Jul 2021 |
1 |
$0 |
4 |
Director |
02 Jul 2021, 18:07 |
| LCTX |
Lineage Cell Therapeutics, Inc. |
01 Jul 2021 |
1 |
$0 |
4 |
Director |
01 Jul 2021, 18:24 |
| LCTX |
Lineage Cell Therapeutics, Inc. |
29 Jun 2021 |
3 |
+$40,366 |
4 |
Director |
30 Jun 2021, 18:58 |
| /report/000147929021000114-russell-angus-c-2021-05-05 |
Revance Therapeutics, Inc. |
05 May 2021 |
2 |
$0 |
4 |
Director |
07 May 2021, 19:12 |